Aura Biosciences reported net income of -$46.10M for the quarter ended Jun 2026. This income statement covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating items | ||||||||||||||||||||||||
| Research & DevelopmentR&D | 6.37M | 7.98M | 8.28M | 9.51M | 11.29M | 13.16M | 14.40M | 15.12M | 15.43M | 20.28M | 17.05M | 16.88M | 17.04M | 22.33M | 23.34M | 22.88M | 22.18M | 21.90M | 27.96M | 30.75M | ||||
| Selling, General & AdministrativeSG&A | 2.53M | 3.65M | 4.54M | 4.31M | 4.76M | 4.45M | 5.04M | 5.16M | 5.06M | 4.50M | 5.26M | 5.88M | 6.20M | 5.47M | 5.69M | 5.73M | 5.73M | 5.34M | 6.91M | 17.32M | ||||
| Other Operating ExpensesOther Opex | -0.01M | -0.31M | ||||||||||||||||||||||
| Operating ExpensesOpex | 8.89M | 11.63M | 12.81M | 13.82M | 16.05M | 17.61M | 19.44M | 20.28M | 20.49M | 24.78M | 22.31M | 22.76M | 23.23M | 27.81M | 29.04M | 28.61M | 27.91M | 27.24M | 34.87M | 48.07M | ||||
| Operating IncomeOp. Inc | -8.89M | -11.63M | -12.81M | -13.82M | -16.05M | -17.61M | -19.44M | -20.28M | -20.49M | -24.78M | -22.31M | -22.76M | -23.23M | -27.81M | -29.04M | -28.61M | -27.91M | -27.24M | -34.87M | -48.07M | ||||
| EBIT | -8.89M | -11.63M | -12.81M | -13.82M | -16.05M | -17.61M | -19.44M | -20.28M | -20.49M | -24.78M | -22.31M | -22.76M | -23.23M | -27.81M | -29.04M | -28.61M | -27.91M | -27.24M | -34.87M | -48.07M | ||||
| Non-operating items | ||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.01M | |||||||||||||||||||||||
| Non Operating Investment IncomeNon-Op. Investment Inc. | -0.01M | |||||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.05M | -0.04M | 0.06M | -0.33M | 0.31M | -0.01M | -0.03M | -0.01M | -0.03M | -0.03M | -0.03M | -0.03M | 3.17M | -0.02M | -0.04M | -0.01M | -2.66M | 0.00M | 0.15M | |||||
| Non Operating IncomeNon Op. Inc. | 0.06M | -0.01M | -0.02M | 0.35M | 0.15M | 1.05M | 1.98M | 1.98M | 1.98M | 2.79M | 2.65M | 2.42M | 2.23M | 2.00M | 1.57M | 1.64M | 1.80M | 1.69M | 1.19M | 2.46M | ||||
| Net income details | ||||||||||||||||||||||||
| EBT | -8.89M | -11.63M | -12.81M | -13.82M | -16.05M | -17.61M | -17.47M | -18.30M | -18.51M | -21.99M | -19.66M | -20.34M | -21.00M | -25.81M | -27.46M | -26.97M | -26.10M | -26.37M | -33.67M | -45.61M | ||||
| Tax ProvisionsTaxes | 0.14M | 0.05M | 0.04M | -18.33M | 0.02M | 0.05M | 0.03M | -22.38M | 0.01M | 0.03M | ||||||||||||||
| Profit After TaxPAT | -8.84M | -11.68M | -12.84M | -13.47M | -15.92M | -16.41M | -17.47M | -18.30M | -18.51M | -22.07M | -19.71M | -20.34M | -21.04M | -26.11M | -27.48M | -27.10M | -26.13M | -25.73M | -33.69M | -46.10M | ||||
| Income from Continuing OperationsIncome (Continuing) | -8.89M | -11.63M | -12.81M | -13.82M | -16.05M | -17.61M | -17.47M | -18.30M | -18.51M | -22.13M | -19.71M | -20.34M | -21.04M | -7.48M | -27.48M | -27.02M | -26.13M | -3.99M | -33.69M | -45.64M | ||||
| Consolidated Net IncomeConsol Net Inc. | -8.89M | -11.63M | -12.81M | -13.82M | -16.05M | -17.61M | -17.47M | -18.30M | -18.51M | -22.13M | -19.71M | -20.34M | -21.04M | -7.48M | -27.48M | -27.02M | -26.13M | -3.99M | -33.69M | -45.64M | ||||
| Income towards Parent CompanyParent Net Inc | -8.89M | -11.63M | -12.81M | -13.82M | -16.05M | -17.61M | -17.47M | -18.30M | -18.51M | -22.13M | -19.71M | -20.34M | -21.04M | -7.48M | -27.48M | -27.02M | -26.13M | -3.99M | -33.69M | -45.64M | ||||
| Net Income towards Common StockholdersNet Income | -8.89M | -11.63M | -12.81M | -13.82M | -16.05M | -17.61M | -17.47M | -18.30M | -18.51M | -22.13M | -19.71M | -20.34M | -21.04M | -7.48M | -27.48M | -27.02M | -26.13M | -3.99M | -33.69M | -45.64M | ||||
| Additional items | ||||||||||||||||||||||||
| EPS (Basic) | -20.15 | -2.25 | -0.44 | -0.47 | -0.55 | -0.59 | -0.46 | -0.48 | -0.48 | -0.56 | -0.40 | -0.41 | -0.42 | -0.15 | -0.55 | -0.47 | -0.40 | -0.07 | -0.50 | -0.48 | ||||
| EPS (Diluted) | -20.15 | -2.25 | -0.44 | -0.47 | -0.55 | -0.59 | -0.46 | -0.48 | -0.48 | -0.56 | -0.40 | -0.41 | -0.42 | -0.15 | -0.55 | -0.47 | -0.40 | -0.07 | -0.50 | -0.48 | ||||
| Shares Outstanding | 0.44M | 5.16M | 29.21M | 29.25M | 29.27M | 29.94M | 37.78M | 37.86M | 38.19M | 39.62M | 49.45M | 49.55M | 49.66M | 49.65M | 50.13M | 58.02M | 65.94M | 60.34M | 67.45M | 94.86M | ||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.44M | 5.16M | 29.21M | 29.25M | 29.27M | 29.94M | 37.78M | 37.86M | 38.19M | 39.62M | 49.45M | 49.55M | 49.66M | 49.65M | 50.13M | 58.02M | 65.94M | 60.34M | 67.45M | 94.86M | ||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.44M | 5.16M | 29.22M | 29.27M | 29.28M | 29.94M | 37.80M | 38.09M | 38.22M | 39.62M | 49.50M | 49.58M | 49.78M | 50.00M | 50.23M | 62.07M | 62.99M | 63.59M | 64.15M | 103.48M | ||||
| EBITDA | -8.89M | -11.63M | -12.81M | -13.82M | -16.05M | -17.61M | -19.44M | -20.28M | -20.49M | -24.78M | -22.31M | -22.76M | -23.23M | -27.81M | -29.04M | -28.61M | -27.91M | -27.24M | -34.87M | -48.07M | ||||
| Interest ExpensesInt Expense | 0.01M | |||||||||||||||||||||||
| Tax Rate | -0.62% | -0.25% | -0.20% | 71.02% | -0.07% | -0.18% | -0.10% | 84.86% | -0.03% | -0.06% |